B Friedman, V N Kapur. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdultAgedAminosalicylic Acids/therapeutic useAntitubercular Agents/adverse effectsAntitubercular Agents/therapeutic useCycloserine/therapeutic useDrug Therapy, CombinationEthambutol/therapeutic useEthionamide/therapeutic useFemaleHospitalizationHumansIsoniazid/therapeutic useKanamycin/therapeutic useMaleMycobacterium tuberculosis/isolation & purificationPyrazinamide/therapeutic usePyridoxine/therapeutic useRifampin/therapeutic useStreptomycin/therapeutic useTuberculosis, Osteoarticular/diagnosisTuberculosis, Osteoarticular/drug therapyTuberculosis, Osteoarticular/surgeryUnited StatesViomycin/therapeutic use
Substances： See more » Aminosalicylic AcidsAntitubercular AgentsPyrazinamideKanamycinEthambutolCycloserinePyridoxineEthionamideIsoniazidRifampinStreptomycinViomycin
Year: 1973 PMID： 4359522 DOI： 10.1097/00003086-197311000-00002
Source DB: PubMed Journal: Clin Orthop Relat Res ISSN： 0009-921X Impact factor: 4.176